Get the Stockscreener App
4.28
2.95%
-0.13
After Hours:
4.28
Sensus Healthcare Inc stock is traded at $4.28, with a volume of 62,249.
It is down -2.95% in the last 24 hours and down -11.57% over the past month.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
See More
Previous Close:
$4.41
Open:
$4.36
24h Volume:
62,249
Relative Volume:
0.64
Market Cap:
$70.47M
Revenue:
$24.41M
Net Income/Loss:
$485.00K
P/E Ratio:
7.5088
EPS:
0.57
Net Cash Flow:
$-2.37M
1W Performance:
+6.47%
1M Performance:
-11.57%
6M Performance:
+32.51%
1Y Performance:
-8.74%
1-Day Range:
$4.21
$4.5138
1-Week Range:
$3.94
$4.90
52-Week Range:
$3.03
$5.92
Sensus Healthcare Inc Stock (SRTS) Company Profile
Name
Sensus Healthcare Inc
Sector
Industry
Phone
561-922-5808
Address
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRTS
Sensus Healthcare Inc
|
4.28 | 72.61M | 24.41M | 485.00K | -2.37M | 0.57 |
|
ABT
Abbott Laboratories
|
111.04 | 196.53B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
370.50 | 146.14B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
93.01 | 122.74B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
72.99 | 107.15B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
83.89 | 49.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-31-25 | Initiated | Lake Street | Buy |
| Nov-15-24 | Reiterated | Maxim Group | Buy |
| Feb-26-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Dec-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-10-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Feb-14-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Nov-07-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jan-29-19 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-26-18 | Initiated | B. Riley FBR | Buy |
| Nov-03-17 | Reiterated | Maxim Group | Buy |
| Jun-06-17 | Initiated | Maxim Group | Buy |
| Aug-08-16 | Initiated | Northland Capital | Outperform |
View All
Sensus Healthcare Inc Stock (SRTS) Latest News
Sensus Healthcare Inc. (SRTS) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Sensus Healthcare 2025 10-K: Revenue $27.48M, EPS $(0.47) - TradingView
Sensus Healthcare (NASDAQ: SRTS) posts 2025 loss and outlines growth strategy - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Sensus Healthcare, Inc. (NASDAQ:SRTS) Given Average Rating of "Hold" by Analysts - MarketBeat
Merger Talk: Is Sensus Healthcare Inc stock risky to hold now2025 AllTime Highs & High Conviction Buy Zone Alerts - baoquankhu1.vn
Aug Fed Impact: What are the future prospects of Sensus Healthcare Inc2025 Technical Patterns & Smart Money Movement Tracker - baoquankhu1.vn
Valuation Update: What are the future prospects of Sensus Healthcare IncJuly 2025 Gainers & Community Verified Trade Signals - baoquankhu1.vn
Sensus Healthcare launches cloud software for radiotherapy systems By Investing.com - Investing.com Australia
Insider Buying: Eric Sachetta Acquires Additional Shares of Sens - GuruFocus
Sachetta Eric buys Sensus Healthcare (SRTS) shares worth $7,620 By Investing.com - Investing.com Nigeria
Sachetta Eric buys Sensus Healthcare (SRTS) shares worth $7,620 - Investing.com
Director Eric Sachetta buys Sensus Healthcare (SRTS) shares in open market - Stock Titan
Sensus Healthcare launches cloud software for radiotherapy systems - Investing.com South Africa
Sensus Healthcare Introduces Sensus Link, Brings Advanced Operating Capabilities to the SRT-100™ Installed Base - Business Wire
Is Sensus Healthcare Inc. stock affected by interest rate hikes2025 Key Highlights & Expert Approved Trade Ideas - mfd.ru
Block Trades: Is Telephone and Data Systems Inc stock influenced by commodity pricesEarnings Beat & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Sensus Healthcare launches financing service for SRT systems - Investing.com India
Why Sensus Healthcare Inc. stock is rated strong buyQuarterly Portfolio Summary & Technical Buy Zone Confirmation - mfd.ru
Sensus Healthcare launches financing service for SRT systems By Investing.com - Investing.com Nigeria
Sensus Launches Sensus Healthcare Financial Services to Facilitate Customer Acquisition of SRT Technology - BioSpace
SRTS: Maxim Group Lowers Price Target, Maintains Buy Rating | SR - GuruFocus
Sensus Healthcare, Inc. (NASDAQ:SRTS) Just Reported And Analysts Have Been Cutting Their Estimates - simplywall.st
Sensus Healthcare, Inc. (NASDAQ:SRTS) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance
Can Sensus Healthcare Inc. stock sustain institutional interest2025 Key Lessons & Real-Time Stock Price Movement Reports - mfd.ru
SRTS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Wall Street Zen Downgrades Sensus Healthcare (NASDAQ:SRTS) to Sell - MarketBeat
SRTS Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Sensus Healthcare Bets on 2026 Reimbursement Rebound - TipRanks
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Sensus Healthcare, Inc. (NASDAQ:SRTS) Q4 2025 Earnings Call Transcript - Insider Monkey
Is Sensus Healthcare Inc. stock risky to hold nowJuly 2025 Intraday Action & Real-Time Volume Trigger Notifications - mfd.ru
Sensus Healthcare, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Sensus Healthcare Inc (SRTS) Q4 2025 Earnings Call Highlights: N - GuruFocus
Sensus Healthcare Q4 Earnings Call Highlights - MarketBeat
Sensus Healthcare SRTS Q4 2025 Earnings Transcript - AOL.com
SRTS: Reimbursement clarity and international growth set the stage for profitability in 2026 - TradingView
Earnings call transcript: Sensus Healthcare’s Q4 2025 earnings miss forecasts By Investing.com - Investing.com India
Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Estimates By $0.10 EPS - MarketBeat
Earnings call transcript: Sensus Healthcare’s Q4 2025 earnings miss forecasts - Investing.com
Sensus Healthcare (SRTS): Q4 Revenue Decline and 2026 Growth Pro - GuruFocus
SRTS: New CMS codes and strong cash position set the stage for growth and profitability in 2026 - TradingView
Sensus Healthcare Reports Fourth Quarter 2025 Financial Results Highlighted by Publication of Dedicated CPT Codes for SRT to Treat Non-Melanoma Skin Cancer - marketscreener.com
Sensus Healthcare (NASDAQ:SRTS) shareholders have endured a 36% loss from investing in the stock three years ago - Yahoo Finance
Can Sensus Healthcare Inc. stock continue upward trendWeekly Trading Summary & Short-Term Trading Opportunity Alerts - mfd.ru
Preview: Sensus Healthcare's Earnings - Benzinga
Quarterly Recap: Is Sensus Healthcare Inc stock a good pick for beginners - baoquankhu1.vn
SRTS News Today | Why did Sensus Healthcare stock go down today? $SRTS - MarketBeat
Analysts Set Sensus Healthcare, Inc. (NASDAQ:SRTS) Target Price at $8.00 - Defense World
Lobbying Update: $15,000 of SENSUS HEALTHCARE INC. lobbying was just disclosed - Quiver Quantitative
Sensus Healthcare Inc Stock (SRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensus Healthcare Inc Stock (SRTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sachetta Eric | Director |
Nov 21 '25 |
Buy |
3.93 |
7,000 |
27,510 |
140,113 |
| Sachetta Eric | Director |
Nov 13 '25 |
Buy |
4.50 |
2,500 |
11,250 |
133,113 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFICER |
Nov 18 '25 |
Buy |
4.03 |
25,000 |
100,750 |
1,200,293 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 18 '25 |
Buy |
3.80 |
1,000 |
3,800 |
118,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 11 '25 |
Buy |
4.26 |
1,000 |
4,260 |
117,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Aug 13 '25 |
Buy |
3.37 |
1,000 |
3,370 |
116,839 |
2.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):